As of April 24, 2025, Ypsomed (YPSN.SW) has a market cap of $5.45 billion USD. According to our data, Ypsomed is ranked No.2466 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 24, 2025 | $5.45 B |
1.22%
|
Dec 30, 2024 | $5.39 B |
8.62%
|
Dec 29, 2023 | $4.96 B |
80.81%
|
Dec 30, 2022 | $2.74 B |
-8.76%
|
Dec 30, 2021 | $3.01 B |
27.79%
|
Dec 30, 2020 | $2.35 B |
13.30%
|
Dec 30, 2019 | $2.08 B |
13.38%
|
Dec 28, 2018 | $1.83 B |
-26.36%
|
Dec 29, 2017 | $2.49 B |
-12.61%
|
Dec 30, 2016 | $2.85 B |
28.39%
|
Dec 30, 2015 | $2.22 B |
69.78%
|
Dec 30, 2014 | $1.31 B |
32.54%
|
Dec 30, 2013 | $0.98 B |
16.17%
|
Dec 28, 2012 | $0.85 B |
2.49%
|
Dec 30, 2011 | $0.83 B |
-2.76%
|
Dec 30, 2010 | $0.85 B |
-11.94%
|
Dec 31, 2009 | $0.97 B |
-19.37%
|
Dec 31, 2008 | $1.20 B |
-13.98%
|
Dec 31, 2007 | $1.39 B |
-16.96%
|
Dec 29, 2006 | $1.68 B |
-45.10%
|
Dec 30, 2005 | $3.06 B |
110.31%
|
Dec 31, 2004 | $1.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novo Nordisk
NVO
|
$273.04 B |
66.814 B
|
![]() Denmark
|
![]() Sanofi
SNY
|
$126.63 B |
-0.001 M
|
![]() France
|
![]() Eli Lilly
LLY
|
$744.81 B |
0.006 M
|
![]() USA
|
![]() Medtronic
MDT
|
$106.93 B |
0.001 M
|
![]() Ireland
|
![]() Abbott Laboratories
ABT
|
$224.14 B |
-0.002 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.09 B |
0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$374.44 B |
0.003 M
|
![]() USA
|
![]() DexCom
DXCM
|
$26.22 B |
-0.001 M
|
![]() USA
|
![]() Insulet
PODD
|
$17.31 B |
-0.001 M
|
![]() USA
|
![]() Tandem Diabetes Care
TNDM
|
$1.10 B |
-0.000 M
|
![]() USA
|
![]() Senseonics Holdings
SENS
|
$0.48 B |
0.000 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$74.20 B |
-0.000 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$212.47 B |
0.000 M
|
![]() UK
|
Market Cap | = | YPSN.SW Stock Price | * | YPSN.SW Shares Outstanding |
= | $399.50 | * | 13.65 M | |
= | $5.45 B |